Design of Receptor-Specific Anticancer Agents for Gallbladder Cancer: Integrating Immunomodulatory Strategies.
Combining receptor-targeted nanomedicine with immunotherapeutic strategies could pave the way for personalized treatment regimens that improve therapeutic outcomes and survival in patients with gallbladder cancer.